Aleksandar Pavic

Aleksandar Pavic

Auto-generated profile, based on publicly available information

Aleksandar Pavic

University of Belgrade, Institute of Molecular Genetics and Genetic Engineering, Belgrade, Serbia

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2015 in Journal of the Serbian Chemical Society
Verified
Journal Article
Open access
PDF file
SSSrdjan Stankovic
Srdjan Stankovic
IMIvana Moric
Ivana Moric
APAleksandar Pavic
Aleksandar Pavic
SVSandra Vojnovic
Sandra Vojnovic
BVBranka Vasiljevic
Branka Vasiljevic
VCVladica Cvetkovic
Vladica Cvetkovic
Bioleaching of samples taken from depths of 10, 15, and 20 meters from old flotation tailings of the Copper Mine Bor was conducted in shaken flasks using extremely acidic water of Lake Robuleas lixiviant. Yield of copper after five weeks of the bioleaching experiment was 68.34?1.21% for 15 m sample, 72.57?0.57% for 20 m sample and 97.78?5.50% for 10 m sample. The obtained results were compared to the results of acid leaching of the same samples and it was concluded that bioleaching was generally more efficient for the treatment of samples taken from depths of 10 m and 20 m. The content of pyrite in the 20 m sample, which contained the highest amount of this mineral, was reduced after bioleaching. Benefits of this approach are: recovery of substantial amounts of copper, reducing the environmental impact of flotation tailings and the application of abundant and free water from the Robule acidic lake as lixiviant. Results of the experiment showed that bioleaching can be more efficient than acid leaching for copper extraction from flotation tailings with higher sulfide contents.

1 January 2014 in Journal of the Serbian Chemical Society
Verified
Journal Article
Open access
PDF file
SSSrdjan Stankovic
Srdjan Stankovic
IMIvana Moric
Ivana Moric
APAleksandar Pavic
Aleksandar Pavic
BVBranka Vasiljevic
Branka Vasiljevic
BJBarrie D. Johnson
Barrie D. Johnson
VCVladica Cvetkovic
Vladica Cvetkovic
An investigation of the microbial diversity of the extremely acidic, metal-rich Lake Robule was carried out using culture-dependant and culture-independent (T-RFLP) methods, and the ability of indigenous bacteria from the lake water to leach copper from a mineral concentrate was tested. T-RFLP analysis revealed that the dominant bacteria in lake water samples were the obligate heterotroph Acidiphilium cryptum (~50% of total bacteria) and the iron-oxidizing autotroph Leptospirillum ferrooxidans (~40%) The iron/sulfur-oxidizing autotroph Acidithiobacillus ferrooxidans had been reported to be the most abundant bacteria in the lake in an earlier study by other authors, but it was not detected in the present study using T-RFLP. Although it was isolated on solid media and detected in enrichment (bioleaching) cultures. The presence of the two bacterial species detected by T-RFLP (L. ferrooxidans and A. cryptum) was also confirmed by cultivation on solid media. The presence and relative abundance of bacteria inhabiting Lake Robule was explained by the physiological characteristics of the bacteria and the physico-chemical characteristics of the lake water.

1 January 2020 in Journal of the Serbian Chemical Society
Verified
Journal Article
Open access
PDF file
PSPetar Stanić
Petar Stanić
Marko RodicMarko Rodic
Marko Rodic
Tanja V. SoldatovicTanja V. Soldatovic
Tanja V. Soldatovic
APAleksandar B. Pavić
Aleksandar B. Pavić
NRNataša S. Radaković
Nataša S. Radaković
MŽMarija D. D Živković
Marija D. D Živković
The 3-arylidene-2-thiohydantoin derivative, 3-[(2-hydroxybenzylidene) amino]-2-thioxoimidazolidin-4-one, was synthesized in a two-step condensation reaction of 2-hydroxybenzaldehyde, thiosemicarbazide and ethyl chloroacetate. The ligand was structurally characterized by NMR and IR spectroscopy, as well as by elemental analysis. In the reaction of the well-known polymeric trans-[CuCl2(DMSO)2]n complex with the polydentate thiohydantoin type ligand, instead of the corresponding copper thiohydantoin complex, unexpectedly, the dinuclear cis-[{CuCl(DMSO)2}(?-Cl)]2 complex (1) was formed predominantly as the final stable product. The structure of the complex 1 was confirmed by single crystal X-ray diffraction analysis. The cis-complex is obtained through assisted isomerization of the trans-form, in which the thiohydantoin derivative has a crucial role.

27 October 2025 in bioRxiv
Verified
Preprint
Open access
KŽKristina Živić
Kristina Živić
MPMarijana Pavlovic
Marijana Pavlovic
MOMarija Ostojić
Marija Ostojić
DGDaniel Galun
Daniel Galun
APAleksandar Pavić
Aleksandar Pavić
Jelena GrahovacJelena Grahovac
Jelena Grahovac
Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive cancer types with a dismal prognosis. Early metastatic dissemination and rich desmoplastic stroma limit therapeutic efficacy, and the discovery of new treatment approaches that will target these obstacles is of great importance. Nischarin (NISCH)/Imidazoline-1 receptor (IR-1) is a potential tumor suppressor, that is involved in the regulation of cell migration, invasion, and cytoskeletal organization. Importantly, several FDA-approved agonists target this receptor. This study aimed to examine the expression of NISCH in PDAC and the effects of its agonists with the intent of drug repurposing. NISCH was expressed in PDAC tumor tissue, in both the epithelial and stromal compartments of tumors, and higher NISCH expression was associated with longer patient survival. Out of the three tested NISCH agonists, rilmenidine was the most potent and could induce cancer cell apoptosis. Rilmenidine treatment induced transcriptional changes in cancer cells associated with so far reported NISCH function and decreased their adhesion and migration in vitro . In CAFs, rilmenidine treatment decreased the expression of activation markers and limited cancer cell-CAF cytokine communication in co-culture. Ultimately, in the in vivo tumor xenograft zebrafish model, rilmenidine reduced the metastatic spread of pancreatic cancer cells. Our results suggest that NISCH agonist rilmenidine is a promising candidate for drug repurposing as an antimetastatic agent in PDAC and that NISCH can be a potential target for the development of new PDAC therapeutics.